CompuGroup Medical SE & Co. KGaA (COP) — Tangible Net Worth Ratio
CompuGroup Medical SE & Co. KGaA (COP) has a Tangible Net Worth Ratio of 6.5% as of March 2025. This metric is calculated by deducting intangible assets (€609.48 Million) from net assets (€652.09 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore CompuGroup Medical SE & Co. KGaA annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
CompuGroup Medical SE & Co. KGaA Tangible Net Worth Ratio (2004–2024)
This chart shows how CompuGroup Medical SE & Co. KGaA's Tangible Net Worth Ratio has changed across 21 annual periods from 2004 to 2024. As of March 2025, the ratio stands at 6.5%, reflecting net assets of €652.09 Million with intangible assets of €609.48 Million EUR. For live market cap and overall valuation, see CompuGroup Medical SE & Co. KGaA market cap and net worth.
Annual Tangible Net Worth Ratio for CompuGroup Medical SE & Co. KGaA (2004–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for CompuGroup Medical SE & Co. KGaA from 2004 to 2024, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore CompuGroup Medical SE & Co. KGaA (COP) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 4.5% | €648.31 Million | €619.45 Million | €1.97 Billion | ▼ -2.1 pp |
| 2023 | 6.5% | €669.27 Million | €625.76 Million | €1.90 Billion | ▲ +3.7 pp |
| 2022 | 2.8% | €673.82 Million | €654.75 Million | €1.94 Billion | ▲ +5.1 pp |
| 2021 | -2.2% | €612.28 Million | €625.94 Million | €1.79 Billion | ▼ -16.8 pp |
| 2020 | 14.6% | €638.94 Million | €545.66 Million | €1.57 Billion | ▲ +44.4 pp |
| 2019 | -29.8% | €259.92 Million | €337.42 Million | €1.07 Billion | ▼ -29.3 pp |
| 2018 | -0.5% | €273.00 Million | €274.33 Million | €848.31 Million | ▲ +14.8 pp |
| 2017 | -15.3% | €236.06 Million | €272.16 Million | €825.01 Million | ▲ +11.0 pp |
| 2016 | -26.3% | €218.65 Million | €276.19 Million | €807.90 Million | ▲ +19.6 pp |
| 2015 | -45.9% | €192.61 Million | €281.11 Million | €791.68 Million | ▲ +9.5 pp |
| 2014 | -55.5% | €175.63 Million | €273.09 Million | €737.55 Million | ▼ -24.4 pp |
| 2013 | -31.1% | €192.64 Million | €252.50 Million | €692.08 Million | ▲ +0.6 pp |
| 2012 | -31.7% | €179.41 Million | €236.31 Million | €651.28 Million | ▲ +13.9 pp |
| 2011 | -45.6% | €168.20 Million | €244.91 Million | €640.71 Million | ▲ +62.8 pp |
| 2010 | -108.4% | €182.73 Million | €380.73 Million | €556.40 Million | ▼ -40.7 pp |
| 2009 | -67.6% | €185.83 Million | €311.47 Million | €451.78 Million | ▼ -5.9 pp |
| 2008 | -61.7% | €182.82 Million | €295.60 Million | €417.33 Million | ▼ -112.8 pp |
| 2007 | 51.1% | €198.02 Million | €96.81 Million | €279.26 Million | ▲ +91.9 pp |
| 2006 | -40.8% | €54.37 Million | €76.54 Million | €220.12 Million | ▼ -27.6 pp |
| 2005 | -13.2% | €44.98 Million | €50.93 Million | €140.77 Million | ▲ +84.9 pp |
| 2004 | -98.2% | €28.87 Million | €57.21 Million | €137.60 Million | — |